Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis
- Study Type:
- EXPANDED_ACCESS
- Last Updated:
- 2024-10-29
Conditions
- Atopic Dermatitis
Interventions
- DRUG
No Results Yet